SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001012975-16-001310
Filing Date
2016-06-21
Accepted
2016-06-21 13:54:39
Documents
1
Effectiveness Date
2016-06-21
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 11924
  Complete submission text file 0001012975-16-001310.txt   13056
Mailing Address 509 S. EXETER ST., SUITE 202 BALTIMORE MD 21202
Business Address 509 S. EXETER ST., SUITE 202 BALTIMORE MD 21202 212-956-1111
Centrexion Therapeutics Corp (Filer) CIK: 0001592052 (see all company filings)

IRS No.: 320402377 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-265466 | Film No.: 161724021